Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods of treating cancer using rad51 small molecule stimulators

a stimulator and small molecule technology, applied in the field of biochemistry, cell biology, oncology, can solve problems such as error-free repair, and achieve the effect of enhancing the toxic effect of imbalances in expression and activity levels

Inactive Publication Date: 2017-01-19
UNIVERSITY OF CHICAGO
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent is about methods for using substances to kill or stop the growth of cancer cells. These methods specifically target proteins called RAD51 and RAD54, which are known to play a role in the development of cancer. The invention is designed to enhance the toxic effects of these proteins, reducing their activity in cancer cells. The technical effect of this patent is to provide new ways for fighting cancer by targeting specific molecules involved in its growth.

Problems solved by technology

HR utilizes an undamaged sister chromatid as a template to guide the repair of DSBs, thereby leading to error-free repair.
Several cancers and cell lines have imbalances in the activity levels of these proteins, making them potentially susceptible to therapies that target RAD51 activity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of treating cancer using rad51 small molecule stimulators
  • Methods of treating cancer using rad51 small molecule stimulators
  • Methods of treating cancer using rad51 small molecule stimulators

Examples

Experimental program
Comparison scheme
Effect test

example 1

Identification of RAD51 Stimulators

[0113]Small molecule RAD51 stimulators were identified from a screen of a small-molecule chemical library as disclosed in Connell et. al. (US 2010 / 0248371), which is hereby incorporated by reference in its entirety. Briefly, a fluorescence polarization assay for RAD51 filament formation was used to screen a 10,000 compound small-molecule library (Chembridge DIVERSet collection) for compounds that stimulate RAD51 filament formation. The screen identified three small molecule compounds that stimulate RAD51 filament formation by at least 50% (FIGS. 8A-8E, compounds 45488 (“RS-1”), 43783, and 41936). Further study of RS-1 confirmed that it enhances RAD51 filament formation and that it protects these filaments from buffers containing high salt concentration (which typically destabilize RAD51 filaments). Imaging with electron microscopy confirmed that the increases in measured fluorescence polarization were, in fact, due to compound-stimulated filaments ...

example 2

Chemical Synthesis of Compounds

[0116]3-Benzylsulfamoyl-4-bromo-N-(4-bromo-phenyl)-benzamide was synthetized by reaction of chlorosulfonic acid with 4-bromobenzoic acid followed by sulfonamide formation with benzylamine and coupling with 4-bromoaniline. 1H NMR and 13C NMR spectra were obtained using a Bruker spectrometer with TMS as an internal standard. The following abbreviations indicating multiplicity were used: s=singlet, d=doublet, t=triplet, m=multiplet. HRMS experiments were carried out using a Shimadzu IT-TOF instrument with MeCN and H2O spiked with 0.1% formic acid as the mobile phase. Reaction progress was monitored by TLC using precoated silica gel plates (Merck silica gel 60 F254, 250 μm thickness). Preparative HPLC was carried out using a Shimadzu preparative liquid chromatograph with the following specifications: column, ACE 5 AQ (150 mm×21.2 mm) with 5 μm particle size; gradient, 25-100% MeOH / H2O, 30 min; 100% MeOH, 5 min; 100-25% MeOH / H2O, 4 min; 25% MeOH / H2O, 1 min;...

example 3

Low Levels of RAD54B and RAD54L Expression Area Associated with Sensitivity to RS-1 in Immortalized Human Cells

[0119]High levels of RAD51 overexpression render cells susceptible to the formation of toxic RAD51 complexes, particularly in cell types that harbor inadequate translocase activity (Shah, et al., 2010). The inventors examined whether malignant human cells with low / limiting levels of RAD54 translocase proteins would be hypersensitive to RS-1, a compound that increases the dNA binding activity of RAD51 (Jayathilaka, et al., 2008), using a panel of immortalized human cell lines. Whole cell levels for RAD51, RAD54L, and RAD54B proteins were measured by western blot, and the quantification for each cell line was normalized to levels in PC3 cells (Table 1). These relative protein levels were directly compared against RS-1 sensitivity (LD90 values) by linear regression analysis. The factor most strongly associated with RS-1 LD90 was RAD54B protein level (R2=0.33). By contrast, the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

Methods of killing or inhibiting the growth cancer cells and tumors and of treating cancer by administering compounds that stimulate the activity of RAD51. Cells overexpressing RAD51 or with other imbalances in homologous recombination machinery are particularly susceptible targets of RAD51 stimulators.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims the benefit of priority of U.S. Provisional Patent Application No. 61 / 950,689, filed Mar. 10, 2014, which is hereby incorporated by reference in its entirety.NOTICE OF GOVERNMENT RIGHTS[0002]This invention was made with government support under CA142642-02 2010-2015 awarded by the National Institutes of Health. The government has certain rights in the invention.BACKGROUND OF THE INVENTION[0003]A. Field of the Invention[0004]The present invention relates generally to the fields of biochemistry, cell biology, and oncology. More specifically, it concerns methods for killing or inhibiting cancer cells by stimulating RAD51 protein activity.[0005]B. Description of Related Art[0006]Homologous recombination (HR) is an essential process that serves multiple roles including the repair of DNA double strand breaks (DSBs). HR utilizes an undamaged sister chromatid as a template to guide the repair of DSBs, thereby leading to er...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/18A61K31/415A61K45/06C07D231/14C07C311/16C07C311/21C07D213/40A61K31/4406A61K31/4709
CPCA61K31/18A61K31/4406A61K31/415A61K45/06C07D231/14C07C311/16C07C311/21C07D213/40A61K31/4709A61K2300/00
Inventor CONNELL, PHILLIP P.BISHOP, DOUGLAS K.BUDKE, BRIANWEICHSELBAUM, RALPH
Owner UNIVERSITY OF CHICAGO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com